Insider transactions

EDGAR

ADAGIO MEDICAL HOLDINGS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
2 transactions, 222,315 shares
Sum of shares × price per share: 243,946.35
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–11 of 11

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-06-16 Filed 2026-08-12Salmon Sean Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Non-qualified stock option (right to buy) — underlying Common Stock (30,000) — exercise price 0.7103
Acquired (A)30,0000—30,000Direct (D) No
F1
  • F1 Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the Option). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Open filing 0001792380-26-000002 Read from the filing’s XML Dispute this row
2026-06-16 Filed 2026-08-12Cox James L Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Non-qualified stock option (right to buy) — underlying Common Stock (30,000) — exercise price 0.7103
Acquired (A)30,0000—30,000Direct (D) No
F1
  • F1 Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the Option). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Open filing 0001665442-26-000002 Read from the filing’s XML Dispute this row
2026-06-16 Filed 2026-08-12GARDINER SANDRA A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Non-qualified stock option (right to buy) — underlying Common Stock (30,000) — exercise price 0.7103
Acquired (A)30,0000—30,000Direct (D) No
F1
  • F1 Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the Option). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Open filing 0001218574-26-000002 Read from the filing’s XML Dispute this row
2026-06-16 Filed 2026-08-12MISHAN ORLY Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Non-qualified stock option (right to buy) — underlying Common Stock (100,000) — exercise price 0.7103
Acquired (A)100,0000—100,000Direct (D) No
F1
  • F1 Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the Option). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Open filing 0001830911-26-000002 Read from the filing’s XML Dispute this row
2026-06-16 Filed 2026-08-12Mirsaeedi-Farahani Keyvan Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Non-qualified stock option (right to buy) — underlying Common Stock (30,000) — exercise price 0.7103
Acquired (A)30,0000—30,000Direct (D) No
F1
  • F1 Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the Option). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Open filing 0002031256-26-000002 Read from the filing’s XML Dispute this row
2026-06-16 Filed 2026-08-12Moran Timothy P. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Non-qualified stock option (right to buy) — underlying Common Stock (30,000) — exercise price 0.7103
Acquired (A)30,0000—30,000Direct (D) No
F1
  • F1 Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the Option). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Open filing 0001753958-26-000002 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-09Kaster Deborah Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (490,500) — exercise price 0.977
Acquired (A)490,5000—490,500Direct (D) No
F1
  • F1 Employee Stock Options granted pursuant to Issuer's 2024 Equity Incentive Plan (the Option). The Option will vest over a four-year period, whereby twenty-five percent (25%) of the Option will vest on October 20, 2026, with the remaining shares subject to the Option vesting in thirty-six (36) equal monthly installments thereafter.
Open filing 0002089223-26-000002 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-09Usen Todd Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (800,000) — exercise price 0.977
Acquired (A)800,0000—800,000Direct (D) No
F1
  • F1 Employee Stock Options granted pursuant to Issuer's 2024 Equity Incentive Plan (the Option). The Option will vest over a four-year period, whereby twenty-five percent (25%) of the Option will vest on March 6, 2027, with the remaining shares subject to the Option vesting in thirty-six (36) equal monthly installments thereafter.
Open filing 0001964615-26-000003 Read from the filing’s XML Dispute this row
2025-12-16 Filed 2025-12-18Kaster Deborah Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)15,0001.1982
17,973

Derived: shares × price per share. Exact value 17973.0000.

15,000Direct (D) No
F1, F2
  • F1 Open market purchase.
  • F2 This transaction was executed in multiple trades at prices ranging from $1.11 to $1.20. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0002089223-25-000002 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-15Usen Todd Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)207,3151.09
225,973.35

Derived: shares × price per share. Exact value 225973.35.

207,315Direct (D) No
F1, F2
  • F1 Open market purchase.
  • F2 This transaction was executed in multiple trades at prices ranging from $0.9258 to $1.14101. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001964615-25-000003 Read from the filing’s XML Dispute this row
2025-12-11 Filed 2025-12-11Salmon Sean Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Non-qualified stock option (right to buy) — underlying Common Stock (90,000) — exercise price 0.8779
Acquired (A)90,0000—90,000Direct (D) No
F1
  • F1 The shares subject to the option will vest in 36 equal monthly installments commencing on January 11, 2026, subject to the Reporting Person's continued services through each such date.
Open filing 0001104659-25-120419 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–24 of 24

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
PERCEPTIVE ADVISORS LLC 9,876,586 SH1,511,117 dollarsUnchanged Prior quarter: 9,876,586Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,258,501 SH192,551 dollarsUnchanged Prior quarter: 1,258,501Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row
Alyeska Investment Group, L.P. 1,159,615 SH177,421 dollarsUnchanged Prior quarter: 1,159,615Open filing 0001172661-26-005329 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager661,191 SH101,162 dollarsHigher by 582,076 Prior quarter: 79,115Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
SILVERARC CAPITAL MANAGEMENT, LLC 170,460 SH26,080 dollarsLower by 53,900 Prior quarter: 224,360Open filing 0001420506-26-002577 Filed 2026-11-12 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager118,729 SH18,166 dollarsNot in the prior quarter’s filings read Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 108,954 SH16,670 dollarsUnchanged Prior quarter: 108,954Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
Affinity Asset Advisors, LLC 80,000 SH12,240 dollarsUnchanged Prior quarter: 80,000Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager76,212 SH11,660 dollarsHigher by 60,057 Prior quarter: 16,155Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
HRT FINANCIAL LP 53,814 SH8 dollarsHigher by 40,109 Prior quarter: 13,705Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 53,782 SH8,229 dollarsUnchanged Prior quarter: 53,782Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
XTX Topco Ltd Partly reported under another manager45,657 SH6,986 dollarsHigher by 27,504 Prior quarter: 18,153Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager39,205 SH5,998 dollarsNot in the prior quarter’s filings read Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager30,875 SH4,724 dollarsUnchanged Prior quarter: 30,875Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
TORONTO DOMINION BANK Partly reported under another manager25,000 SH3,825 dollarsUnchanged Prior quarter: 25,000Open filing 0002052595-26-000123 Filed 2026-11-16 Dispute this row
Point72 Asset Management, L.P. 20,143 SH3,082 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
Opaleye Management Inc. 18,444 SH2,822 dollarsUnchanged Prior quarter: 18,444Open filing 0001420506-26-002880 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager14,215 SH2,175 dollarsHigher by 2,684 Prior quarter: 11,531Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
Vanguard Personalized Indexing Management, LLC 11,960 SH1,830 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-127786 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager9,347 SH1,346 dollarsNot in the prior quarter’s filings read Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager4,267 SH653 dollarsLower by 2,187 Prior quarter: 6,454Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
Robinhood Markets, Inc. 469 SH71 dollarsNot in the prior quarter’s filings read Open filing 0000950157-26-001278 Filed 2026-11-18 Dispute this row
Strategic Financial Concepts, LLC 19 SH3 dollarsNot in the prior quarter’s filings read Open filing 0001754960-26-001004 Filed 2026-11-16 Dispute this row
BARCLAYS PLC Partly reported under another manager1 SH0 dollarsLower by 22 Prior quarter: 23Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • ADAR1 Capital Management, LLC 1,205,447 SH
  • Sio Capital Management, LLC 698,989 SH
  • Shaolin Capital Management LLC 171,170 SH
  • CITIGROUP INC 13,255 SH
  • UBS Group AG 2,268 SH
  • Crewe Advisors LLC 500 SH
  • MORGAN STANLEY 137 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Perceptive Advisors LLC Common Stock, par value $0.0001 per share44.4523,35609/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-463801 Dispute this row
Joseph Edelman Common Stock, par value $0.0001 per share44.4523,35609/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-463801 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.0001 per share43.9516,66009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-463801 Dispute this row
C2 Life Sciences LLC Common Stock, par value $0.0001 per share0.76,69609/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 4Open filing 0001193125-26-463801 Dispute this row
ADAR1 Capital Management, LLC Common Stock, par value $0.0001 per share5.41,205,447.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-097340 Dispute this row
Daniel Schneeberger Common Stock, par value $0.0001 per share5.41,205,447.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-26-097340 Dispute this row
Sio Capital Management, LLC Common Stock, par value, $0.0001 per share3.15698,989.0006/30/2026 Filed 2026-07-28SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-009111 Dispute this row
Perceptive Advisors LLC Common Stock, par value $0.0001 per share55.415,321,65503/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 3Open filing 0001193125-26-226569 Dispute this row
Joseph Edelman Common Stock, par value $0.0001 per share55.415,321,65503/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 3Open filing 0001193125-26-226569 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.0001 per share54.715,120,75303/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 3Open filing 0001193125-26-226569 Dispute this row
C2 Life Sciences LLC Common Stock, par value $0.0001 per share0.9200,90203/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 3Open filing 0001193125-26-226569 Dispute this row
Adage Capital Management, L.P. Common Stock, par value $0.0001 per share5.671,258,501.0003/31/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0000919574-26-002906 Dispute this row
Robert Atchinson Common Stock, par value $0.0001 per share5.671,258,501.0003/31/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0000919574-26-002906 Dispute this row
Phillip Gross Common Stock, par value $0.0001 per share5.671,258,501.0003/31/2026 Filed 2026-05-13SCHEDULE 13G/AAmendment 2Open filing 0000919574-26-002906 Dispute this row
ADAR1 Capital Management, LLC Common Stock, par value $0.0001 per share5.71,205,447.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001104659-26-016658 Dispute this row
Daniel Schneeberger Common Stock, par value $0.0001 per share5.71,205,447.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001104659-26-016658 Dispute this row
Alyeska Investment Group, L.P. Common Stock, par value $0.0001per share9.92,096,784.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001172661-26-001152 Dispute this row
Alyeska Fund GP, LLC Common Stock, par value $0.0001per share9.92,096,784.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001172661-26-001152 Dispute this row
Anand Parekh Common Stock, par value $0.0001per share9.92,096,784.0012/31/2025 Filed 2026-02-17SCHEDULE 13GOpen filing 0001172661-26-001152 Dispute this row
Perceptive Advisors LLC Common Stock, par value $0.0001 per share57.515,321,65512/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0001193125-26-054521 Dispute this row
Joseph Edelman Common Stock, par value $0.0001 per share57.515,321,65512/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0001193125-26-054521 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.0001 per share56.815,120,75312/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0001193125-26-054521 Dispute this row
C2 Life Sciences LLC Common Stock, par value $0.0001 per share0.8200,90212/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0001193125-26-054521 Dispute this row
Sio Capital Management, LLC Common Stock, par value, $0.0001 per share6.081,288,461.0012/31/2025 Filed 2026-02-11SCHEDULE 13GOpen filing 0001214659-26-001504 Dispute this row
Adage Capital Management, L.P. Common Stock, par value $0.0001per share6.881,058,501.0009/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-004885 Dispute this row
Robert Atchinson Common Stock, par value $0.0001per share6.881,058,501.0009/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-004885 Dispute this row
Phillip Gross Common Stock, par value $0.0001per share6.881,058,501.0009/30/2025 Filed 2025-11-13SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-004885 Dispute this row
RA Capital Management, L.P. Common Stock, par value $0.0001 per share7.21,200,000.0006/30/2025 Filed 2025-08-26SCHEDULE 13G/AAmendment 4Open filing 0001415889-25-023033 Dispute this row
Peter Kolchinsky Common Stock, par value $0.0001 per share7.21,200,000.0006/30/2025 Filed 2025-08-26SCHEDULE 13G/AAmendment 4Open filing 0001415889-25-023033 Dispute this row
Rajeev Shah Common Stock, par value $0.0001 per share7.21,200,000.0006/30/2025 Filed 2025-08-26SCHEDULE 13G/AAmendment 4Open filing 0001415889-25-023033 Dispute this row
RA Capital Healthcare Fund, L.P. Common Stock, par value $0.0001 per share6.91,140,000.0006/30/2025 Filed 2025-08-26SCHEDULE 13G/AAmendment 4Open filing 0001415889-25-023033 Dispute this row
RA Capital Management, L.P. Common Stock, par value $0.0001 per share0.00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-021993 Dispute this row
Peter Kolchinsky Common Stock, par value $0.0001 per share0.00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-021993 Dispute this row
Rajeev Shah Common Stock, par value $0.0001 per share0.00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-021993 Dispute this row
RA Capital Healthcare Fund, L.P. Common Stock, par value $0.0001 per share0.00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001415889-25-021993 Dispute this row
Adage Capital Management, L.P. Common Stock, par value $0.0001 per share5.34821,261.0006/30/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000902664-25-003511 Dispute this row
Robert Atchinson Common Stock, par value $0.0001 per share5.34821,261.0006/30/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000902664-25-003511 Dispute this row
Phillip Gross Common Stock, par value $0.0001 per share5.34821,261.0006/30/2025 Filed 2025-08-12SCHEDULE 13GOpen filing 0000902664-25-003511 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,538,477 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020166,957
2021249,835
2022229,495
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to ADAGIO MEDICAL HOLDINGS, INC.